Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.

Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.
复制标题

DOI:
10.1186/1471-2407-10-391
复制
发表时间:
2010-07-23
期刊:
影响因子:
3.8
通讯作者:
Kim CW
Kim CW
中科院分区:
医学2区
文献类型:
--
作者:
Jang JY;Jeon YK;Kim CW

文献摘要

参考文献

被引文献

相似文献

在乳腺癌中,属于表皮生长因子受体家族的HER 2/neu癌蛋白可能触发磷酸肌醇-3激酶(PI 3 K)/Akt通路的激活,该通路控制细胞增殖、存活、迁移和侵袭。在这项研究中,我们研究了腺嘌呤核苷酸移位酶2(ANT 2)短发夹RNA(shRNA)介导的HER 2/neu下调和对PI 3 K/Akt信号通路的抑制作用是否抑制乳腺癌细胞的迁移和侵袭的问题。我们利用基于ANT 2载体的RNA干扰方法来抑制ANT 2表达,并且在整个研究中使用HER 2/neu过表达的人乳腺癌细胞系SK-BR 3。在这项研究中,ANT 2 shRNA通过促进HER 2/neu蛋白与热休克蛋白90(HSP 90)解离而降解,从而降低HER 2/neu蛋白水平。结果表明,ANT 2 shRNA对PI 3 K/Akt信号通路有抑制作用。通过抑制PI 3 K/Akt信号通路,可下调膜型基质金属蛋白酶1(MT 1-MMP)和血管内皮生长因子(VEGF)的表达,降低基质金属蛋白酶2(MMP 2)和MMP 9的活性,抑制乳腺癌细胞的迁移和侵袭。这些结果表明,通过shRNA敲低ANT 2通过抑制HSP 90的功能下调HER 2/neu,并抑制PI 3 K/Akt信号通路,最终导致乳腺癌细胞的迁移和侵袭受到抑制。
In breast cancer, the HER2/neu oncoprotein, which belongs to the epidermal growth factor receptor family, may trigger activation of the phosphoinositide-3 kinase (PI3K)/Akt pathway, which controls cell proliferation, survival, migration, and invasion. In this study, we examined the question of whether or not adenine nucleotide translocase 2 (ANT2) short hairpin RNA (shRNA)-mediated down-regulation of HER2/neu and inhibitory effects on the PI3K/Akt signaling pathway suppressed migration and invasiveness of breast cancer cells. We utilized an ANT2 vector-based RNA interference approach to inhibition of ANT2 expression, and the HER2/neu-overexpressing human breast cancer cell line, SK-BR3, was used throughout the study. In this study, ANT2 shRNA decreased HER2/neu protein levels by promoting degradation of HER2/neu protein through dissociation from heat shock protein 90 (HSP90). As a result, ANT2 shRNA induced inhibitory effects on the PI3K/Akt signaling pathway. Inhibition of PI3K/Akt signaling by ANT2 shRNA caused down-regulation of membrane-type 1 matrix metalloproteinase (MT1-MMP) and vascular endothelial growth factor (VEGF) expression, decreased matrix metalloproteinase 2 (MMP2) and MMP9 activity, and suppressed migration and invasion of breast cancer cells. These results indicate that knock-down of ANT2 by shRNA down-regulates HER2/neu through suppression of HSP90's function and inhibits the PI3K/Akt signaling pathway, resulting ultimately in suppressed migration and invasion of breast cancer cells.
DOI: 10.1200/jco.1999.17.9.2639
发表时间: 1999-09-01
影响因子: 45.3
作者:
Cobleigh, MA;Vogel, CL;Slamon, DJ
通讯作者: Slamon, DJ
DOI: 10.1158/1078-0432.ccr-06-0646
发表时间: 2006-12-15
影响因子: 11.5
作者:
Ono, Mayumi;Kuwano, Michihiko
通讯作者: Kuwano, Michihiko
DOI: 10.1186/bcr1857
发表时间: 2008
期刊: Breast cancer research : BCR
影响因子: --
作者:
Jang JY;Choi Y;Jeon YK;Kim CW
通讯作者: Kim CW
DOI: 10.1073/pnas.97.8.3884
发表时间: 2000-04-11
影响因子: 11.1
作者:
Fang, JM;Shing, Y;Moses, MA
通讯作者: Moses, MA
DOI: 10.1126/science.3798106
发表时间: 1987-01-09
期刊: SCIENCE
影响因子: 56.9
作者:
SLAMON, DJ;CLARK, GM;MCGUIRE, WL
通讯作者: MCGUIRE, WL